Interaction of oxazaphosphorines with multidrug resistance-associated protein 4 (MRP4)

AAPS Journal

Volumn 12, Issue 3, 2010, Pages 300-308

  Zhang, Jing ^a   Ng, Ka Yun ^a,b   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

cyclophosphamide; cytotoxicity; drug transporter; ifosfamide; multidrug resistance associated protein 4

Indexed keywords

ADEFOVIR DIPIVOXIL; BUTHIONINE SULFOXIMINE; CELECOXIB; CLOFIBRATE; CYCLOPHOSPHAMIDE; DICLOFENAC; IFOSFAMIDE; MESSENGER RNA; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 4; VERLUKAST; ABCC4 PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; PHOSPHORUS DERIVATIVE; PRIMER DNA;

ARTICLE; CANCER RESISTANCE; CELL SPECIFICITY; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SPECIFICITY; EMBRYO; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; KIDNEY CELL; PROTEIN EXPRESSION; CELL LINE; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; VALIDATION STUDY;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CELL LINE; CYCLOPHOSPHAMIDE; DNA PRIMERS; HUMANS; IFOSFAMIDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHOSPHORUS COMPOUNDS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77955944179     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-010-9189-x     Document Type: Article

References (35)

1. PF Juranka RL Zastawny V Ling 1989 P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins Faseb J. 3 2583 92 1:CAS:528:DyaK3cXmvFagsg%3D%3D 2574119
2. K Lee AJ Klein-Szanto GD Kruh 2000 Analysis of the MRP4 drug resistance profile in transfected NIH3T3 cells J Natl Cancer Inst. 92 1934 40 10.1093/jnci/92.23.1934 1:CAS:528:DC%2BD3cXptVegsr4%3D 11106685
3. M Leggas M Adachi GL Scheffer D Sun P Wielinga G Du, et al. 2004 Mrp4 confers resistance to topotecan and protects the brain from chemotherapy Mol Cell Biol 24 7612 21 10.1128/MCB.24.17.7612-7621.2004 1:CAS:528: DC%2BD2cXntVKhurs%3D 15314169
4. MD Norris J Smith K Tanabe P Tobin C Flemming GL Scheffer, et al. 2005 Expression of multidrug transporter MRP4/ABCC4 is a marker of poor prognosis in neuroblastoma and confers resistance to irinotecan in vitro Mol Cancer Ther. 4 547 53 10.1158/1535-7163.MCT-04-0161 1:CAS:528:DC%2BD2MXjtFegs7o%3D 15827327
5. K Nooter G Brutel de la Riviere MP Look KE van Wingerden SC Henzen-Logmans RJ Scheper, et al. 1997 The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer Br J Cancer 76 486 93 1:CAS:528:DyaK2sXlvV2nsLo%3D 9275026
6. M Filipits G Pohl M Rudas O Dietze S Lax R Grill, et al. 2005 Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group J Clin Oncol. 23 1161 8 10.1200/JCO.2005.03.033 1:CAS:528:DC%2BD2MXitl2gurw%3D 15718312
7. F Leonessa R Clarke 2003 ATP binding cassette transporters and drug resistance in breast cancer Endocr Relat Cancer. 10 43 73 10.1677/erc.0.0100043 1:CAS:528:DC%2BD3sXksVahtLk%3D 12653670
8. IF Faneyte PM Kristel MJ van de Vijver 2004 Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer Anticancer Res 24 2931 9 1:CAS:528:DC%2BD2cXhtVSjsLvF 15517899
9. CH Graham H Kobayashi KS Stankiewicz S Man SJ Kapitain RS Kerbel 1994 Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents J Natl Cancer Inst. 86 975 82 10.1093/jnci/86.13.975 1:CAS:528:DyaK2cXmt1WhsL4%3D 8007019
10. G Chen BA Teicher E Frei 1998 Biochemical characterization of in vivo alkylating agent resistance of a murine EMT-6 mammary carcinoma. Implication for systemic involvement in the resistance phenotype Cancer Biochem Biophys 16 139 55 1:CAS:528:DyaK1MXisFSquw%3D%3D 9923973
11. FY Lee 1991 Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites Br J Cancer 63 45 50 1:CAS:528:DyaK3MXhvF2hsrg%3D 1989664
12. G Chen DJ Waxman 1995 Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells Biochem Pharmacol 49 1691 701 10.1016/0006-2952(95)00079-F 1:CAS:528:DyaK2MXmt1ShsLc%3D 7786310
13. LQ Lai TM Tan 2002 Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues Biochem J 361 497 503 10.1042/0264-6021:3610497 1:CAS:528: DC%2BD38XhslOqsbY%3D 11802779
14. M Rius J Hummel-Eisenbeiss AF Hofmann D Keppler 2006 Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione Am J Physiol Gastrointest Liver Physiol. 290 G640 9 10.1152/ajpgi.00354.2005 1:CAS:528:DC%2BD28Xks1Slsb0%3D 16282361
15. J Carmichael WG DeGraff AF Gazdar JD Minna JB Mitchell 1987 Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing Cancer Res 47 936 42 1:CAS:528:DyaL2sXhsVyrtb0%3D 3802100
16. G Reid P Wielinga N Zelcer I van der Heijden A Kuil M de Haas, et al. 2003 The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs Proc Natl Acad Sci USA 100 9244 9 10.1073/pnas.1033060100 1:CAS:528: DC%2BD3sXmtlyktrg%3D 12835412
17. M Rius AT Nies J Hummel-Eisenbeiss G Jedlitschky D Keppler 2003 Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4) localized to the basolateral hepatocyte membrane Hepatology. 38 374 84 10.1053/jhep.2003. 50331 1:CAS:528:DC%2BD3sXmvFSmtbk%3D 12883481
18. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2 - Δ \Δ Ct method Methods 25 402 8 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D 11846609
19. G Reid P Wielinga N Zelcer M De Haas L Van Deemter J Wijnholds, et al. 2003 Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5 Mol Pharmacol 63 1094 103 10.1124/mol.63.5.1094 1:CAS:528:DC%2BD3sXjt12lu7Y%3D 12695538
20. JS Moffit LM Aleksunes JM Maher GL Scheffer CD Klaassen JE Manautou 2006 Induction of hepatic transporters multidrug resistance-associated proteins (Mrp) 3 and 4 by clofibrate is regulated by peroxisome proliferator-activated receptor alpha J Pharmacol Exp Ther. 317 537 45 10.1124/jpet.105.093765 1:CAS:528:DC%2BD28XktFamtLk%3D 16467456
21. J Zhang Q Tian SY Chan SC Li S Zhou W Duan, et al. 2005 Metabolism and transport of oxzaphosphorines and the clinical implications Drug Metab Rev 37 611 703 10.1080/03602530500364023 1:CAS:528:DC%2BD28XmslWg 16393888
22. N Tepsiri L Chaturat B Sripa W Namwat S Wongkham V Bhudhisawasdi, et al. 2005 Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines World J Gastroenterol 11 2748 53 1:CAS:528:DC%2BD2MXlslKitLo%3D 15884115
23. T Konno T Ebihara K Hisaeda T Uchiumi T Nakamura T Shirakusa, et al. 2003 Identification of domains participating in the substrate specificity and subcellular localization of the multidrug resistance proteins MRP1 and MRP2 J Biol Chem. 278 22908 17 10.1074/jbc.M302868200 1:CAS:528:DC%2BD3sXksF2iurg%3D 12682044
24. J Estape M Daniels N Vinolas P Santabarbara JJ Grau S Gardella 1990 Combination chemotherapy with oral etoposide plus intravenous cyclophosphamide in liver metastases of breast cancer Am J Clin Oncol 13 98 100 10.1097/00000421-199004000-00002 1:STN:280:DyaK3c7psF2msg%3D%3D 2316488
25. MF Fromm HM Kauffmann P Fritz O Burk HK Kroemer RW Warzok, et al. 2000 The effect of rifampin treatment on intestinal expression of human MRP transporters Am J Pathol 157 1575 80 1:CAS:528:DC%2BD3cXosFyhsrY%3D 11073816
26. D Schrenk PR Baus N Ermel C Klein B Vorderstemann HM Kauffmann 2001 Up-regulation of transporters of the MRP family by drugs and toxins Toxicol Lett 120 51 7 10.1016/S0378-4274(01)00306-X 1:CAS:528:DC%2BD3MXivFejs7k%3D 11323161
27. S Teng V Jekerle M Piquette-Miller 2003 Induction of ABCC3 (MRP3) by pregnane X receptor activators Drug Metab Dispos 31 1296 9 10.1124/dmd.31.11. 1296 1:CAS:528:DC%2BD3sXosV2qtb0%3D 14570758
28. C Chen CD Klaassen 2004 Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility Biochem Biophys Res Commun 317 46 53 10.1016/j.bbrc.2004.03.014 1:CAS:528:DC%2BD2cXisVKmsbc%3D 15047146
29. JM Maher X Cheng AL Slitt MZ Dieter CD Klaassen 2005 Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver Drug Metab Dispos 33 956 62 10.1124/dmd.105.003798 1:CAS:528:DC%2BD2MXlslWqs7c%3D 15833929
30. M Assem EG Schuetz M Leggas D Sun K Yasuda G Reid, et al. 2004 Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice J Biol Chem. 279 22250 7 10.1074/jbc.M314111200 1:CAS:528:DC%2BD2cXjvF2rsbs%3D 15004017
31. JM Maher LM Aleksunes MZ Dieter Y Tanaka JM Peters JE Manautou, et al. 2008 Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid Toxicol Sci. 106 319 28 10.1093/toxsci/kfn177 1:CAS:528:DC%2BD1cXhtlGht7vI 18757529
32. JD Tugwood TC Aldridge KG Lambe N Macdonald NJ Woodyatt 1996 Peroxisome proliferator-activated receptors: structures and function Ann N Y Acad Sci 804 252 65 10.1111/j.1749-6632.1996.tb18620.x 1:CAS:528:DyaK2sXhtVehur8%3D 8993548
33. M Ammerschlaeger J Beigel KU Klein SO Mueller 2004 Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes Toxicol Sci. 78 229 40 10.1093/toxsci/kfh071 1:CAS:528:DC%2BD2cXjt1aqsbY%3D 14976357
34. SN Barnes LM Aleksunes L Augustine GL Scheffer MJ Goedken AB Jakowski, et al. 2007 Induction of hepatobiliary efflux transporters in acetaminophen- induced acute liver failure cases Drug Metab Disposit. 35 1963 9 10.1124/dmd.107.016170 1:CAS:528:DC%2BD2sXhtFantr7O
35. SN Campion R Johnson LM Aleksunes MJ Goedken N Rooijen GL Scheffer, et al. 2008 Hepatic Mrp4 induction following acetaminophen exposure is dependent on Kupffer cell function Am J Physiol Gastrointest Liver Physiol. 295 294 304 10.1152/ajpgi.00541.2007